Real-world outcomes of inotuzumab ozogamicin treatment for adult relapsed or refractory acute lymphoblastic leukemia: a result from Korea post-marketing surveillance.

Saved in:
Bibliographic Details
Title: Real-world outcomes of inotuzumab ozogamicin treatment for adult relapsed or refractory acute lymphoblastic leukemia: a result from Korea post-marketing surveillance.
Authors: Yoon JH; Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Yang DH; Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National Medical School, Hwasun, Republic of Korea., Cheong JW; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea., Byun JM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Yoo KH; Division of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Woo J; Pfizer Pharmaceutical Korea Ltd., Seoul, Republic of Korea., Kim YM; Pfizer Pharmaceutical Korea Ltd., Seoul, Republic of Korea., Lee S; Department of Internal Medicine, Ewha Womans University Mokdong Hospital, College of Medicine, Ewha Womans University 1071, Anyangcheon-ro, Yangcheon-gu, Seoul, 07985, Republic of Korea. leeseok@catholic.ac.kr.
Source: Annals of hematology [Ann Hematol] 2026 Feb 05; Vol. 105 (3), pp. 91. Date of Electronic Publication: 2026 Feb 05.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41642398
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world outcomes of inotuzumab ozogamicin treatment for adult relapsed or refractory acute lymphoblastic leukemia: a result from Korea post-marketing surveillance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yoon+JH%22">Yoon JH</searchLink>; Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink>; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yang+DH%22">Yang DH</searchLink>; Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National Medical School, Hwasun, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Cheong+JW%22">Cheong JW</searchLink>; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Byun+JM%22">Byun JM</searchLink>; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yoo+KH%22">Yoo KH</searchLink>; Division of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Woo+J%22">Woo J</searchLink>; Pfizer Pharmaceutical Korea Ltd., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+YM%22">Kim YM</searchLink>; Pfizer Pharmaceutical Korea Ltd., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; Department of Internal Medicine, Ewha Womans University Mokdong Hospital, College of Medicine, Ewha Womans University 1071, Anyangcheon-ro, Yangcheon-gu, Seoul, 07985, Republic of Korea. leeseok@catholic.ac.kr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2026 Feb 05; Vol. 105 (3), pp. 91. <i>Date of Electronic Publication: </i>2026 Feb 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41642398
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00277-026-06838-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 91
    Titles:
      – TitleFull: Real-world outcomes of inotuzumab ozogamicin treatment for adult relapsed or refractory acute lymphoblastic leukemia: a result from Korea post-marketing surveillance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yoon JH
      – PersonEntity:
          Name:
            NameFull: Lee JH
      – PersonEntity:
          Name:
            NameFull: Yang DH
      – PersonEntity:
          Name:
            NameFull: Cheong JW
      – PersonEntity:
          Name:
            NameFull: Byun JM
      – PersonEntity:
          Name:
            NameFull: Yoo KH
      – PersonEntity:
          Name:
            NameFull: Woo J
      – PersonEntity:
          Name:
            NameFull: Kim YM
      – PersonEntity:
          Name:
            NameFull: Lee S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 02
              Text: 2026 Feb 05
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0584
          Numbering:
            – Type: volume
              Value: 105
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Annals of hematology
              Type: main
ResultId 1